Literature DB >> 15201191

A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy.

R A C Hughes1, T Umapathi, I A Gray, N A Gregson, M Noori, A S Pannala, A Proteggente, A V Swan.   

Abstract

To investigate the aetiology of chronic idiopathic axonal polyneuropathy (CIAP), 50 consecutive patients were compared with 50 control subjects from the same region. There were 22 patients with painful neuropathy and 28 without pain, 26 with sensory neuropathy and 24 with sensory and motor neuropathy. The typical picture was a gradually progressive sensory or sensory and motor neuropathy. It caused mild or sometimes moderate disability, and reduced the quality of life. There was no evidence that alcohol, venous insufficiency, arterial disease or antibodies to peripheral nerve antigens played a significant part. There was a possible history of peripheral neuropathy in the first or second-degree relatives of six patients and no controls (P = 0.01), and claw toes were present in 12 patients and four controls (P = 0.03). Thirty-two per cent of the patients and 14% of the controls had impaired glucose tolerance or fasting hyperglycaemia but, after adjusting for age and sex, the difference was not significant (P = 0.45), even in the painful neuropathy subgroup. The mean (SD) fasting insulin concentrations were significantly (P = 0.01) higher in the patients [75.9 (44.4) mmol/l] than the controls [47.3 (37.9) mmol/l], and the mean was higher still in the painful neuropathy subgroup [92.2 (37.1) mmol/l] (P < 0.0001). However, insulin resistance as assessed using the homeostasis model assessment formula was not significantly greater in the patients, even in those with pain, than the controls. After adjustment for body mass index as well as age and sex, there was no significant difference in the serum cholesterol concentrations, but there were significantly higher triglyceride concentrations in the patients [mean 1.90 (1.41) mmol/l] than the controls [mean 1.25 (0.79] mmol/l) (P = 0.02). In the patients with painful peripheral neuropathy, the mean triglyceride concentration was 2.37 (1.72), which was even more significantly greater compared with the controls (P = 0.003). In conclusion, CIAP is a heterogeneous condition. A logistic regression analysis identified environmental toxin exposure and hypertriglyceridaemia, but not glucose intolerance or alcohol overuse as significant risk factors that deserve further investigation as possible causes of CIAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201191     DOI: 10.1093/brain/awh192

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  49 in total

Review 1.  Drug therapy for chronic idiopathic axonal polyneuropathy.

Authors:  Janna Warendorf; Alexander Fje Vrancken; Ivo N van Schaik; Richard Ac Hughes; Nicolette C Notermans
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

2.  Tests and expenditures in the initial evaluation of peripheral neuropathy.

Authors:  Brian Callaghan; Ryan McCammon; Kevin Kerber; Xiao Xu; Kenneth M Langa; Eva Feldman
Journal:  Arch Intern Med       Date:  2012-01-23

3.  A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale.

Authors:  R C Graham; R A C Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

4.  The meaning of distal sensory loss and absent ankle reflexes in relation to age: a meta-analysis.

Authors:  Alexander F J E Vrancken; Sandra Kalmijn; Frans Brugman; Gabriël J E Rinkel; Nicolette C Notermans
Journal:  J Neurol       Date:  2005-11-23       Impact factor: 4.849

Review 5.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

6.  Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy.

Authors:  Wei Wang; Chen Wang; D Brian Dawson; Erik C Thorland; Patrick A Lundquist; Bruce W Eckloff; Yanhong Wu; Saurabh Baheti; Jared M Evans; Steven S Scherer; Peter J Dyck; Christopher J Klein
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

7.  Does prediabetes cause small fiber sensory polyneuropathy? Does it matter?

Authors:  C D Kassardjian; P J B Dyck; J L Davies; Rickey E Carter; P J Dyck
Journal:  J Neurol Sci       Date:  2015-05-27       Impact factor: 3.181

Review 8.  Neurological consequences of obesity.

Authors:  Phillipe D O'Brien; Lucy M Hinder; Brian C Callaghan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2017-06       Impact factor: 44.182

9.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849

10.  Neuropathy of impaired glucose tolerance and its measurement.

Authors:  Andrew J M Boulton; Rayaz A Malik
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.